Home
Zydus Lifesciences Ltd 52 Week Low

Zydus Lifesciences Ltd
NSE: ZYDUSLIFE
YEARLOW
Key Highlights
- The 52 Week Low of Zydus Lifesciences Ltd is ₹ 862.2 as of 27 Feb 25 .
Company Fundamentals for Zydus Lifesciences Ltd
Market Price of Zydus Lifesciences Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
27 Feb 2025 | 886.5 |
25 Feb 2025 | 882.55 |
24 Feb 2025 | 890.6 |
21 Feb 2025 | 885.1 |
20 Feb 2025 | 900.2 |
19 Feb 2025 | 891.4 |
18 Feb 2025 | 913.2 |
17 Feb 2025 | 924.15 |
14 Feb 2025 | 901.6 |
13 Feb 2025 | 942.45 |
Asset Value vs Market Value of Zydus Lifesciences Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Historical Revenue of Zydus Lifesciences Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Zydus Lifesciences Ltd
Historical Net Profit of Zydus Lifesciences Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Zydus Lifesciences Ltd
Zydus Lifesciences Ltd News Hub
Zydus Life gains as Q1 PAT climbs 31% YoY to Rs 1,420 cr
Revenue from operations jumped 20.77% year on year (YoY) to Rs 6,207.5 crore in the quareter ended 3
Read more
09 Aug 24
Zydus Lifesciences consolidated net profit rises 30.64% in the June 2024 quarter
Net profit of Zydus Lifesciences rose 30.64% to Rs 1419.90 crore in the quarter ended June 2024 as a
Read more
09 Aug 24
Zydus receives USFDA approval for Valbenazine Capsules
Zydus Lifesciences has received final approval from the United States Food and Drug Administration (
Read more
09 Aug 24
Zydus Lifesciences Ltd soars 1.83%, rises for third straight session
Zydus Lifesciences Ltd is up for a third straight session in a row. The stock is quoting at Rs 1296.
Read more
08 Aug 24